NewsRoom Articles - Page 603 of 1456

WednesdayOct 14, 2020 1:15 pm

MediPharm Labs Corp (TSX: LABS) (OTCQX: MEDIF) Featured in Virtual Coverage of Benzinga’s Cannabis Capital Conference

MediPharm Labs Corp (TSX: LABS) (OTCQX: MEDIF) was founded in 2015 and specializes in the production of purified, pharmaceutical-quality cannabis oil and concentrates as well as advanced derivative products utilizing a Good Manufacturing Practices certified facility with ISO standard-built clean rooms. MediPharm Labs has invested in an expert, research-driven team, state-of-the-art technology, downstream purification methodologies and purpose-built facilities with five primary extraction lines for delivery of pure, trusted and precision-dosed cannabis API and derivative products for its patients and customers. Through its wholesale and white-label platforms, they formulate, consumer-test, process, package and distribute cannabis extracts and advanced cannabinoid-based products to…

WednesdayOct 14, 2020 1:12 pm

Pure Extract Technologies Inc. Leveraging Growing Popularity of Medicinal Mushrooms in Mainstream Medicine

Scientific research suggests some mushrooms can provide mental benefits, anti-tumor effects, improved immune function, anti-viral properties and detoxification “Psychedelic” varieties currently being studied for depression, anxiety, PTSD, bipolar disorder, Alzheimer’s disease, addiction Pure Extracts is expanding into functional mushroom market; Company is currently licensed by Health Canada to buy, sell, produce cannabis products Mushrooms have been used for thousands of years in Eastern medicine to combat illness, increase mental cognition and improve digestion. As their popularity continues to increase worldwide, Pure Extract Technologies, a privately held, plant-based, Canadian extraction company is leveraging the growing acceptance by mainstream science and the…

WednesdayOct 14, 2020 1:00 pm

MariMed (OTCQX: MRMD) Featured in Virtual Coverage of Benzinga’s Cannabis Capital Conference

MariMed Inc. (MRMD: OTCQX) (the “Company” or MariMed), a leading multi-state cannabis and hemp operator focused on health and wellness, today announced today that its CEO will be participating in the Benzinga’s Cannabis Capital Conference. The MariMed team has won 17 cannabis licenses in six states where it has developed over 300,000 square feet of state-of-the-art, regulatory compliant cannabis cultivation, production, and dispensary facilities. Its proprietary in-house branded flower, Nature’s Heritage™ and its infused product brand Betty’s Eddies™ are top sellers in Massachusetts, Rhode Island, and Maryland. MariMed’s CEO Bob Fireman will be questioned by Managing Director of Benzinga Cannabis,…

WednesdayOct 14, 2020 12:45 pm

KushCo Holdings (OTCQX: KSHB) Featured in Virtual Coverage of Benzinga’s Cannabis Capital Conference

KushCo Holdings (OTCQX: KSHB) is an U.S.-based company that sells packaging, vape hardware, solvents, and other ancillary products and services to the legal cannabis and CBD industries. Founded in 2010, KushCo Holdings has now sold more than 1 billion units to growers, processors and producers across North America, South America, and Europe. Nick Kovacevich, CEO of KushCo Holdings, will be hosting a keynote presentation at the upcoming Benzinga Cannabis Capital Conference. To learn more about KushCo Holdings, visit https://www.kushco.com/ For registration information and further details on Benzinga’s Cannabis Capital Conference, visit https://www.benzinga.com/events/cannabis/virtual/ About InvestorBrandNetwork’s Virtual Coverage The InvestorBrandNetwork (“IBN”), a multifaceted…

WednesdayOct 14, 2020 12:34 pm

180 Life Sciences Corp. Bringing Hope to Those Afflicted by Dupuytren’s Disease and Other Inflammatory Conditions

180 Life Sciences is a clinical-stage biotechnology company developing anti-tumor necrosis factor (“TNF”) therapies to treat a variety of inflammatory conditions. Phase 2b/3 clinical trials on fibrosis and inflammation-causing TNF irregularity are currently underway with first results expected in 2021 The company is to be acquired by a SPAC (NASDAQ: KBLM) (NASDAQ: KBLMR) (NASDAQ: KBLMW) and will be listed on the Nasdaq Capital Market under ticker symbol ATNF Pioneering biotech company, 180 Life Sciences Corp. is bringing hope to sufferers of Dupuytren’s Disease and other inflammatory conditions caused by an impaired immune system. Currently, the company has three major programs…

WednesdayOct 14, 2020 12:30 pm

Halo Labs Inc. (OTCQX: AGEEF) Featured in Virtual Coverage of Benzinga’s Cannabis Capital Conference

Halo Labs Inc. (OTCQX: AGEEF) is a US cannabis extraction company focused on developing and manufacturing leading cannabis oil and concentrate products. Founded in Oregon, Halos has produced over 4.5 million grams of oils and concentrates since inception and currently sells upwards of 200 thousand grams per month. The company is currently operating in California and Oregon, as well as in Nevada with partner Just Quality, LLC, and in Lesotho with the Bophelo strategic partnership. Separately, Halo has recently acquired Dispensary Track, a platform which helps alleviate customer flow constrains experienced by dispensaries and enables direct consumer interaction. Kiran Sindu,…

WednesdayOct 14, 2020 12:15 pm

Flowr Corporation (TSX.V: FLWR) (OTC: FLWPF) Featured in Virtual Coverage of Benzinga’s Cannabis Capital Conference

Flowr Corporation (TSX.V: FLWR) (OTC: FLWPF) is a Canadian-based cannabis producer aiming to service the premium segment of dry flower market while catering to the recreational market in Canada and the medicinal market in Europe. Flowr Corporation operate two production facilities located at their campus in Kelowna, British Columbia - namely Kelowna 1, which is the company’s flagship 85,000 square foot indoor facility capable of producing approximately 10,000 kg of premium dry flower as well as Flowr Forest, a 330,000 square foot outdoor/shade-house grow which is capable of producing 10,000 kg of cannabis destined to be used as inputs for…

WednesdayOct 14, 2020 12:00 pm

Dixie Brands (CSE: DIXI.U) (OTCQX: DXBRF) Featured in Virtual Coverage of Benzinga’s Cannabis Capital Conference

Dixie Brands (CSE: DIXI.U) (OTCQX: DXBRF) is located in Denver, Colorado, and through its affiliates across the country, has been formulating and producing award-winning THC and CBD-infused products since 2009. What began as a single flagship product, the Dixie Elixir (a THC-infused soda) has now expanded to over 30 different products across over 100 SKUs, representing the industry’s finest edibles, tinctures, topicals and connoisseur-grade extractions. Chuck Smith, President & CEO of Dixie Brands, will be forming part of a panel discussion entitled “Next Generation in Cannabis Products”, alongside executives from Foria, 1906 and 1933 Industries Inc. at the upcoming Benzinga…

WednesdayOct 14, 2020 11:45 am

Delta 9 Cannabis Inc. (TSX: DN) (OTCQX: VRNDF) Featured in Virtual Coverage of Benzinga’s Cannabis Capital Conference

Delta 9 Cannabis Inc (TSX: DN) (OTCQX: VRNDF) was initially founded in in 2012 by father and son team, Bill and John Arbuthnot, and obtained a license to distribute medical cannabis in March 2014, becoming the 4th Licensed Producer of medical cannabis in Canada. Today, the company has a well-established 80,000 square foot production facility in East Winnipeg and has seen its numbers swell from 2 to 300 employees. Delta 9 Cannabis Inc. (“D9”) is a vertically integrated cannabis company that primarily serves the recreational cannabis market in Canada. D9 operates through three primary business divisions: (1) cultivation & wholesale,…

WednesdayOct 14, 2020 11:30 am

Cresco Labs (CSE: CL) (OTCQX: CRLBF) Featured in Virtual Coverage of Benzinga’s Cannabis Capital Conference

Cresco Labs (CSE: CL) (OTCQX: CRLBF) is a publicly traded, vertically integrated cannabis and medical marijuana company based in Chicago, Illinois, with current retail operations in nine states where marijuana has been legalized for medical use. The company currently operates 15 production facilities within its operational regions, having been granted 29 retail licenses and running 19 wholly owned dispensaries. Separately, Cresco Labs currently focuses on a broad product portfolio which include cannabis products, edibles and soft-gel cannabis derivatives marketed through six key brands, namely Cresco, Cresco Reserve, Remedi, Mindy’s, Good News and High Supply. To learn more about Cresco Labs,…

Financial news and publishing for public and private companies

Contact us: 512.354.7000